Higher olive oil intake tied to lower risk for dementia-related death
May 08, 2024
The findings were seen among US adults irrespective of overall diet quality.
Bad air is bad for brains, study concludes
By
John O'Connor
Sep 18, 2018
Breathing polluted air may lead to dementia later in life, according to a new study by the National Bureau of Economic Research.
Distressing dreams tied to cognitive decline, all-cause dementia
Oct 12, 2022
The findings were seen among middle-aged and older adults without cognitive impairment or Parkinson’s disease at baseline.
Dual decline in memory, gait speed tied to higher dementia risk
Jun 08, 2022
The authors say it is important to assess gait in dementia risk assessments.
Continuity of care benefits those with dementia, healthcare system
By
Lois A. Bowers
Jul 27, 2016
Continuity of care for people who have dementia results in lower costs to the healthcare system and fewer adverse events for those with the disease, according to a new study.
A-fib linked to increased odds of MCI, dementia in women
Jul 05, 2023
Women with atrial fibrillation and normal baseline cognition had higher risk of disease progression from normal to MCI, MCI to dementia
Drug combo may rase dementia risk
By
John O'Connor
Feb 01, 2015
People with atrial fibrillation may face a higher risk for dementia if they are subjected to a drug combination for a prolonged period, researchers have found.
Recommendations to reduce disparities in dementia care due in 2021
By
Kimberly Bonvissuto
Dec 09, 2020
Final recommendations on ways to reduce disparities in dementia, which were developed during a stakeholder roundtable sponsored by the Milken Institute Alliance to Improve Dementia Care, will be released...
Psychological interventions may reduce depression in dementia patients
May 04, 2022
Treatments based on cognitive behavioral therapies may reduce depressive symptoms, but evidence is lacking for their effect on anxiety.
DOACs reduce dementia risk versus warfarin in A-Fib
Sep 07, 2023
Significant reductions were seen in dementia risk for rivaroxaban, apixaban and dabigatran versus warfarin in a network meta-analysis.